GSK Investigational Site

Stanford, California 94305

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Stanford, CA
Click here to add this to my saved trials
Scleroderma, Systemic Clinical Trial
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Stanford, CA
Click here to add this to my saved trials
Neoplasms Clinical Trial
Pilot Immunotherapy With Autologous T-cells Specific for New York Esophageal Antigen-1 (NY-ESO-1)/ Cancer-testis Antigen-2 (LAGE-1a)-Positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Stanford, CA
Click here to add this to my saved trials